Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: real-life experience
Background. Dupilumab is a treatment approved for uncontrolled moderate-to-severe atopic dermatitis (AD). Tropical and developing countries such as Colombia have characteristics that may impact the natural history of AD and access to medical treatments. In that sense, we aimed to describe the effect...
- Autores:
-
Londoño, Julián
Pérez, Lucia
Moreno, Sergio
Chapman, Edgardo
Beatriz García, María
Celis, Ana María
Muñoz, María Angélica
Castillo, David
Sánchez, Jorge
Arevalo, Yaicith
Lozano, Ana
Muñoz, Cesar
Botero, Laura
Beltran, Catalina
García, Elizabeth
Alvis Zakzuk, Nelson Rafael
Alvis Zakzuk, Nelson J.
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2023
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/10454
- Acceso en línea:
- https://hdl.handle.net/11323/10454
https://repositorio.cuc.edu.co/
- Palabra clave:
- Atopic dermatitis
Dupilumab
Eczema
Biologic therapy
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)